Definium Therapeutics DFTX
NASDAQ DFTX
$35.87 +0.38 (+1.07%)
As of: Oct 22, 2026 · 11:43 AM EDT

Definium Therapeutics (DFTX) Net Equity Issued and Repurchased (2021 - 2026)

Updated

Definium Therapeutics' Net Equity Issued and Repurchased was $801.17 million in Q2 2026.

Analysis

Definium Therapeutics (DFTX) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Definium Therapeutics' Net Equity Issued and Repurchased was $1.06 billion through Jun 30, 2026, up 332.0% year-over-year; for FY2025, it was $258.86 million, up 3.5% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 29.2% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $250 million in FY2024, $7.53 million in FY2023 (-82.2%), $42.3 million in FY2022 (-48.4%) and $81.92 million in FY2021 (+13.8%).
  • The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2021.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q4 2023 (growth of 915.8%); the worst was Q1 2022 (a decline of 99.9%).
  • Per Business Quant data, DFTX's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $3.83 million (Q1 2026), $257.85 million (Q4 2025) and $425,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,172.00 Bn 1,140.58 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 639.12 Bn 557.64 Bn 17.26 Bn 138.00 Mn
3 AbbVie 502.23 Bn 475.34 Bn 12.70 Bn -9.00 Mn
4 Merck 375.29 Bn 329.67 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 302.99 Bn 266.98 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 268.68 Bn 242.36 Bn 12.86 Bn 6.00 Mn
7 Amgen 242.24 Bn 197.64 Bn 7.24 Bn -
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn -346.00 Mn
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn -
10 Definium Therapeutics 3.98 Bn 1.90 Bn - 808.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 808.68 Mn
Mar 31, 2026 5.31 Mn
Dec 31, 2025 261.81 Mn
Sep 30, 2025 749,000.00
Jun 30, 2025 97,000.00
Mar 31, 2025 1.00 Mn
Dec 31, 2024 253.88 Mn
Sep 30, 2024 32,000.00
Jun 30, 2024 3.89 Mn
Mar 31, 2024 2.17 Mn
Dec 31, 2023 7.58 Mn
Sep 30, 2023 -1.74 Mn
Jun 30, 2023 1.27 Mn
Mar 31, 2023 583,000.00
Dec 31, 2022 730,000.00
Sep 30, 2022 59.40 Mn
Jun 30, 2022 590,000.00
Mar 31, 2022 241,000.00
Dec 31, 2021 127,000.00
Sep 30, 2021 820,000.00
API Access

Definium Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DFTX&period=max&api_key=YOUR_API_KEY